FGF21 is required for the metabolic benefits of IKKε/TBK1 inhibition

Shannon M. Reilly(Cornell University), Alan R. Saltiel(University of Michigan)
Journal of Clinical Investigation
April 6, 2021
Cited by 20


Related Papers